Paliperidone Extended-Release Tablets and Retacrit
Determining the interaction of Paliperidone Extended-Release Tablets and Retacrit and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: paliperidone
Brand name: Invega, Invega Sustenna, Invega Trinza
Synonyms: Paliperidone
Generic Name: epoetin alfa
Brand name: Epogen, Procrit, Retacrit
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Paliperidone Extended-Release Tablets-Retapamulin
- Paliperidone Extended-Release Tablets-Retapamulin topical
- Paliperidone Extended-Release Tablets-Retapamulin Topical application
- Paliperidone Extended-Release Tablets-Retavase
- Paliperidone Extended-Release Tablets-Retavase Half-Kit
- Paliperidone Extended-Release Tablets-Reteplase
- Retacrit-Paliperidone injection
- Retacrit-Paliperidone Intramuscular
- Retacrit-Palladone
- Retacrit-Palmitate-A
- Retacrit-Palonosetron
- Retacrit-Palonosetron Hydrochloride